Partial agonist

Results: 13



#Item
1A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral–CA1 synapses in hippocampus

A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral–CA1 synapses in hippocampus

Add to Reading List

Source URL: falk.mccormick.northwestern.edu

Language: English - Date: 2011-03-29 13:34:55
    2Neuropharmacology and neurotoxicologyNeuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13 Patric K. Stantona, Pamela E. Potterb, Jennifer Aguilara, Maria Decandiaa and Joseph R. Moskal

    Neuropharmacology and neurotoxicologyNeuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13 Patric K. Stantona, Pamela E. Potterb, Jennifer Aguilara, Maria Decandiaa and Joseph R. Moskal

    Add to Reading List

    Source URL: falk.mccormick.northwestern.edu

    Language: English - Date: 2011-03-29 13:34:57
      3NEWS & VIEWS  shapes for implementation in imagers. This technology heralds the advent of new classes of imaging devices with wide-angle fields of view, low distortion and compact size.

      NEWS & VIEWS shapes for implementation in imagers. This technology heralds the advent of new classes of imaging devices with wide-angle fields of view, low distortion and compact size.

      Add to Reading List

      Source URL: www.ucl.ac.uk

      Language: English - Date: 2008-08-06 17:50:16
      4EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West

      EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West

      Add to Reading List

      Source URL: epa.gov

      Language: English - Date: 2013-04-10 16:29:24
      5OASAS Buprenorphine Reimbursement in OTP Clinical Guidelines: Opiate agonist (methadone) and partial agonist (buprenorphine) medications can each be dispensed by Opioid Treatment Programs certified by OASAS in accordance

      OASAS Buprenorphine Reimbursement in OTP Clinical Guidelines: Opiate agonist (methadone) and partial agonist (buprenorphine) medications can each be dispensed by Opioid Treatment Programs certified by OASAS in accordance

      Add to Reading List

      Source URL: www.oasas.ny.gov

      Language: English - Date: 2014-08-01 14:34:52
      6© 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology  LETTERS Coupling ligand structure to specific conformational switches in the b2-adrenoceptor

      © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology LETTERS Coupling ligand structure to specific conformational switches in the b2-adrenoceptor

      Add to Reading List

      Source URL: med.stanford.edu

      Language: English - Date: 2009-12-04 19:10:52
      7THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 27, Issue of July 6, pp[removed]–24436, 2001 © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.  Accelerated Publication

      THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 27, Issue of July 6, pp[removed]–24436, 2001 © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Accelerated Publication

      Add to Reading List

      Source URL: med.stanford.edu

      Language: English - Date: 2009-12-04 19:10:03
      8EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West

      EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West

      Add to Reading List

      Source URL: www.epa.gov

      Language: English - Date: 2013-04-10 16:29:24
      9Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist)

      Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist)

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      10SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist)

      SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist)

      Add to Reading List

      Source URL: www.fda.gov

      Language: English